Inventor
BRYAN C. BARNHART
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
C12NMicroorganisms or enzymes8%
PatentTitleYear
12,492,238Glypican-3-binding fibronectin based scaffold molecules202511,952,427Anti-CD40 antibodies and uses thereof202411,524,992Glypican-3-binding fibronectin based scaffold molecules202211,352,440Antibodies against CD73 and uses thereof202211,306,149Anti-CD40 antibodies and uses thereof202211,213,586Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (6)· patent assignee history
2022–2024Patents assigned to CYTOMX THERAPEUTICS INC (2)· patent assignee history
2022–2024Based in US· patent location history
2025Based in CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 6 | 2022–2025 |
| CYTOMX THERAPEUTICS INC | 2 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2024 |
| CA | 1 | 2025 |